Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$233.08 - $265.59 $938,380 - $1.07 Million
-4,026 Reduced 4.69%
81,834 $20.3 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $16.7 Million - $19 Million
74,199 Added 636.3%
85,860 $20.6 Million
Q1 2023

May 15, 2023

SELL
$239.75 - $277.0 $16.4 Million - $18.9 Million
-68,302 Reduced 85.42%
11,661 $2.94 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $1.12 Million - $1.31 Million
4,645 Added 6.17%
79,963 $21.2 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $2.43 Million - $14.8 Million
-9,843 Reduced 11.56%
75,318 $19.5 Million
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $5.11 Million - $6.45 Million
21,536 Added 33.85%
85,161 $21.6 Million
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $16.4 Million - $20.1 Million
63,625 New
63,625 $18.7 Million
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $1.19 Million - $1.38 Million
-5,602 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$177.16 - $215.33 $992,450 - $1.21 Million
5,602 New
5,602 $1.21 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $720,977 - $990,601
-5,602 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $133,407 - $185,785
-1,099 Reduced 16.4%
5,602 $775,000
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $29,221 - $33,632
234 Added 3.62%
6,701 $958,000
Q1 2018

May 15, 2018

SELL
$92.16 - $103.8 $73,359 - $82,624
-796 Reduced 10.96%
6,467 $633,000
Q4 2017

Feb 13, 2018

SELL
$85.26 - $94.62 $58,488 - $64,909
-686 Reduced 8.63%
7,263 $674,000
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $630,276 - $703,089
7,949
7,949 $682,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Lombard Odier Asset Management (Europe) LTD Portfolio

Follow Lombard Odier Asset Management (Europe) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.